Syndromes: Sanfilippo syndrome
A look at Sanfilippo syndrome, a progressive and rare congenital lysosomal disorder
Sanfilippo syndrome, or mucopolysaccharidosis (MPS) type III, is a progressive and rare congenital lysosomal disorder caused by an enzyme deficiency in the degradation of heparan sulphate. One of seven MPS types with four subtypes: A, B, C and D (Whitley et al 2018), it affects one in 70,000 live births. Subtypes A and B are more common than C and D (Andrade et al 2015, Lavery et al 2017).
A high absorption level of mucopolysaccharides in the cells of the brain and central nervous system causes the characteristic neurological and developmental difficulties (Kartal 2016, National Organization for Rare Disorders 2017):
- One to four years: deceleration in mental development.
- Four to five years: challenging
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Learning Disability Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests